Osteoporosis is a global public health problem, with fractures contributing to significant
morbidity and mortality. Although postmenopausal osteoporosis is most common, up to 30 …

Bone and mineral disorders occur frequently in kidney transplant recipients and are
associated with a high risk of fracture, morbidity, and mortality. There is a broad spectrum of …

Introduction The application of high-resolution peripheral quantitative computed tomography
(HR-pQCT) to assess bone microarchitecture has grown rapidly since its introduction in …

The risk of mineral and bone disorders among patients with chronic kidney disease is
substantially elevated, owing largely to alterations in calcium, phosphorus, vitamin D …

Fragility fractures are a growing problem worldwide, and current methods for diagnosing
osteoporosis do not always identify individuals who require treatment to prevent a fracture …

Renal osteodystrophy (ROD) is the bone component of chronic kidney disease mineral and
bone disorder (CKD MBD). ROD affects bone quality and strength through the numerous …

In postmenopausal osteoporosis, switching from teriparatide to denosumab results in
continued bone mineral density (BMD) gains whereas switching from denosumab to …

Background Bone and mineral disorders commonly affect kidney transplant (KTx) recipients
and have been associated with a high risk of fracture. Bisphosphonates may prevent or treat …

Results A total of 37 out of 56 participants received a kidney transplant, of which 27
underwent successful repeat bone biopsy. The proportion of patients with high bone …

Bone and mineral disorders are common after organ transplantation. Osteoporosis post
transplantation is associated with increased morbidity and mortality. Pathogenesis of bone …